Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypersensitivity | 3 | 2017 | 25 | 1.700 |
Why?
|
| Asthma | 3 | 2015 | 397 | 1.140 |
Why?
|
| Food Hypersensitivity | 3 | 2016 | 8 | 1.080 |
Why?
|
| Rhinitis, Allergic, Seasonal | 3 | 2013 | 5 | 0.990 |
Why?
|
| Rhinitis, Allergic, Perennial | 3 | 2013 | 7 | 0.990 |
Why?
|
| Immunoglobulin E | 3 | 2018 | 47 | 0.690 |
Why?
|
| Otolaryngology | 1 | 2017 | 17 | 0.620 |
Why?
|
| Disease Management | 1 | 2017 | 114 | 0.580 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2013 | 22 | 0.480 |
Why?
|
| Air Pollutants | 1 | 2013 | 20 | 0.460 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 101 | 0.450 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 374 | 0.440 |
Why?
|
| Skin Tests | 4 | 2018 | 15 | 0.410 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2011 | 2 | 0.410 |
Why?
|
| Humans | 17 | 2018 | 29093 | 0.350 |
Why?
|
| Gastroesophageal Reflux | 1 | 2008 | 25 | 0.320 |
Why?
|
| Respiratory Tract Diseases | 1 | 2008 | 30 | 0.320 |
Why?
|
| Child | 5 | 2016 | 2219 | 0.310 |
Why?
|
| Immunotherapy | 3 | 2016 | 69 | 0.270 |
Why?
|
| Oils | 1 | 2004 | 3 | 0.260 |
Why?
|
| Snoring | 1 | 2004 | 8 | 0.260 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 493 | 0.240 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2011 | 9 | 0.200 |
Why?
|
| Infant | 3 | 2015 | 969 | 0.200 |
Why?
|
| Infant, Newborn | 2 | 2013 | 598 | 0.180 |
Why?
|
| Complementary Therapies | 2 | 2018 | 75 | 0.160 |
Why?
|
| Desensitization, Immunologic | 1 | 2017 | 3 | 0.160 |
Why?
|
| Cost of Illness | 2 | 2015 | 63 | 0.160 |
Why?
|
| Avoidance Learning | 1 | 2017 | 18 | 0.150 |
Why?
|
| Allergens | 2 | 2018 | 16 | 0.140 |
Why?
|
| Age Factors | 2 | 2016 | 1108 | 0.140 |
Why?
|
| Lymphadenitis | 1 | 2015 | 3 | 0.130 |
Why?
|
| Community-Acquired Infections | 1 | 2015 | 31 | 0.130 |
Why?
|
| Anti-Allergic Agents | 1 | 2015 | 7 | 0.130 |
Why?
|
| Prevalence | 2 | 2015 | 896 | 0.130 |
Why?
|
| Immunologic Tests | 1 | 2014 | 5 | 0.130 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 57 | 0.130 |
Why?
|
| Child, Preschool | 3 | 2015 | 1167 | 0.130 |
Why?
|
| Airway Resistance | 1 | 2013 | 5 | 0.120 |
Why?
|
| Environmental Pollution | 1 | 2013 | 4 | 0.120 |
Why?
|
| Diet | 1 | 2016 | 354 | 0.120 |
Why?
|
| Airway Obstruction | 1 | 2013 | 31 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 111 | 0.120 |
Why?
|
| Radiography, Thoracic | 1 | 2013 | 43 | 0.120 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2013 | 71 | 0.110 |
Why?
|
| Recurrence | 1 | 2013 | 235 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2013 | 108 | 0.110 |
Why?
|
| Environment, Controlled | 1 | 2012 | 3 | 0.110 |
Why?
|
| Female | 6 | 2015 | 18164 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3099 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 90 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 2011 | 67 | 0.100 |
Why?
|
| United States | 3 | 2015 | 3630 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 88 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 863 | 0.090 |
Why?
|
| Dermatitis, Atopic | 1 | 2011 | 86 | 0.090 |
Why?
|
| Adult | 4 | 2015 | 8420 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2015 | 369 | 0.090 |
Why?
|
| Pepsin A | 1 | 2008 | 8 | 0.080 |
Why?
|
| Otitis Media with Effusion | 1 | 2008 | 10 | 0.080 |
Why?
|
| Laryngeal Diseases | 1 | 2008 | 10 | 0.080 |
Why?
|
| Rhinitis | 1 | 2008 | 11 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 66 | 0.080 |
Why?
|
| Sinusitis | 1 | 2008 | 17 | 0.080 |
Why?
|
| Pregnancy | 1 | 2011 | 815 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2013 | 1305 | 0.080 |
Why?
|
| Adolescent | 2 | 2015 | 3254 | 0.080 |
Why?
|
| Histamine Antagonists | 2 | 2018 | 5 | 0.070 |
Why?
|
| Male | 4 | 2015 | 17807 | 0.070 |
Why?
|
| Quality of Life | 3 | 2018 | 816 | 0.070 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 273 | 0.070 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 391 | 0.070 |
Why?
|
| Lubrication | 1 | 2004 | 1 | 0.060 |
Why?
|
| Tape Recording | 1 | 2004 | 6 | 0.060 |
Why?
|
| Acoustics | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 94 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2004 | 130 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2004 | 501 | 0.060 |
Why?
|
| Comorbidity | 2 | 2015 | 540 | 0.060 |
Why?
|
| Polymyositis | 1 | 2002 | 1 | 0.050 |
Why?
|
| Deglutition Disorders | 1 | 2002 | 50 | 0.050 |
Why?
|
| Nasal Decongestants | 1 | 2018 | 2 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2018 | 10 | 0.040 |
Why?
|
| Probiotics | 1 | 2018 | 8 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 24 | 0.040 |
Why?
|
| Endoscopy | 1 | 2018 | 40 | 0.040 |
Why?
|
| Physical Examination | 1 | 2018 | 82 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 2018 | 83 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2018 | 87 | 0.040 |
Why?
|
| Biological Products | 1 | 2018 | 66 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 148 | 0.040 |
Why?
|
| Cytokines | 1 | 2018 | 243 | 0.040 |
Why?
|
| Sociology | 1 | 2015 | 2 | 0.030 |
Why?
|
| Causality | 1 | 2015 | 37 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 55 | 0.030 |
Why?
|
| Turbinates | 1 | 2015 | 2 | 0.030 |
Why?
|
| Leukotriene Antagonists | 1 | 2015 | 8 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 24 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 30 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 2015 | 16 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2015 | 38 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 53 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 159 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2015 | 113 | 0.030 |
Why?
|
| Continental Population Groups | 1 | 2015 | 221 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2015 | 149 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 207 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 285 | 0.030 |
Why?
|
| Middle Aged | 1 | 2004 | 10829 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 3531 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 3111 | 0.020 |
Why?
|
| Inhalation | 1 | 2002 | 8 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2002 | 19 | 0.010 |
Why?
|